In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function

American Journal of Kidney Diseases

Volumn 35, Issue 1, 2000, Pages 112-121

  Mackenzie, Ruth K ^a,b,c   Jones, Suzanne ^a,b,c   Moseley, Andrew ^a,b,c   Holmes, Clifford J ^a,b,c   Argyle, Ruth ^a,b,c   Williams, John D ^a,b,c   Coles, Gerald A ^a,b,c   Pu, Kewei ^a,b,c   Faict, Dirk ^a,b,c   Topley, Nicholas ^a,b,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c Baxter R and D Europe   (Belgium)

Author keywords

Bicarbonate buffered PDF; Bicarbonate lactate buffered PDF; Biocompatibility; Lactate buffered PDF (Lac PDF); Peritoneal dialysis (PD); Peritoneal dialysis fluid (PDF); Peritoneal macrophage (PMO)

Indexed keywords

BICARBONATE; DIALYSIS FLUID; LACTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; DIALYSIS; FEMALE; HUMAN; HUMAN CELL; KIDNEY DISEASE; MACROPHAGE FUNCTION; MALE; PERITONEAL DIALYSIS; PERITONEUM MACROPHAGE;

EID: 0033961441     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70309-X     Document Type: Article

References (46)

1. A Jörres JD Williams N Topley Peritoneal dialysis solution biocompatibility: Inhibitory mechanisms and recent studies with bicarbonate-buffered peritoneal dialysis solutions Perit Dial Int 17 suppl 1 1997 S42 S46
2. A Jörres GM Gahl U Frei Peritoneal dialysis fluid biocompatibility: Does it really matter? Kidney Int 46 suppl 48 1994 S79 S86
3. N Topley JD Williams Effect of peritoneal dialysis on cytokine production by peritoneal cells Blood Purif 14 1996 188 197
4. N Topley HM Alobaidi M Davies GA Coles JD Williams D Lloyd The effect of dialysate on peritoneal phagocyte oxidative metabolism Kidney Int 34 1988 404 411
5. CWH de Fijter HA Verbrugh EDJ Peters PL Oe J van der Meulen J Verhoef AJM Donker In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD Clin Nephrol 39 1993 75 80
6. M Feriani S Biasioli D Borin A Brendolan L Gargantini S Chiaramonte A Fabris C Ronco G La Greca Bicarbonate solutions for peritoneal dialysis: A reality Int J Artif Organs 8 1985 57 58
7. RL Veech The untoward effects of the anions of dialysis fluids Kidney Int 34 1988 587 597
8. JC Griffin SC Marie Glucose degradation in the presence of sodium lactate during autoclaving at 121°C Am J Hosp Pharmacol 15 1958 893 895
9. KR Heimlich AN Martin A kinetic study of glucose degradation in acid solution J Am Pharm Assoc 49 1960 592 597
10. RB Taylor BM Jappy JM Neil Kinetics of dextrose degradation under autoclaving conditions J Pharm Pharmacol 23 1971 121 129
11. NE Webb GJ Sperandio AN Martin A study of the composition of glucose solutions J Am Pharm Assoc 47 1958 101 103
12. LA Cooker P Luneburg D Faict C Choo CJ Holmes Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags Perit Dial Int 17 1997 373 378
13. N Topley D Kaur MM Petersen A Jörres J Passlick-Deetjen GA Coles JD Williams Biocompatibility of bicarbonate-buffered peritoneal dialysis fluids: Influence on mesothelial cell and neutrophil function Kidney Int 49 1996 1447 1456
14. N Topley D Kaur MM Petersen A Jörres JD Williams D Faict CJ Holmes In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial cell and neutrophil function J Am Soc Nephrol 7 1996 218 224
15. AW Yu Z Olabi DK Gupta FQ Zhou VC Gandhi TS Ing Effect of euhydric peritoneal dialysis solutions containing a mixture of bicarbonate and lactate or lactate alone on neutrophilic superoxide production ASAIO J 40 1994 M900 M901
16. XJ Zhou AW Yu FQ Zhou FKM Wong TS Ing ND Vaziri Neutrophil intracellular pH after exposure of neutrophils to a euhydric, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart Int J Artif Organs 18 1995 69 72
17. XJ Zhou AW Yu FQ Zhou J Ryu TS Ing ND Vaziri Effects of an acidic, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart on neutrophilic intracellular pH Int J Artif Organs 16 1993 816 819
18. TS Ing DA Huie V Johnson J Ryu AW Yu FKM Wong FQ Zhou Effects of lactate-based and bicarbonate-based peritoneal dialysis solutions on neutrophilic oxygen consumption Artif Organs 19 1995 440 442
19. GJ Dobos J Böhler J Kuhlmann J Elsner M Andre J Passlick-Deetjen PJ Schollmeyer Bicarbonate-based dialysis solutions preserves granulocyte functions Perit Dial Int 14 1994 366 370
20. FJ Manahan BL Ing JC Chan DK Gupta FQ Zhou I Pal MA Rahman Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on superoxide production by human neutrophils Artif Organs 13 1989 495 497
21. H-P Fischer U Schenk T Kiefer E Hübel S Thomas H Yatzidis T Mettang U Kuhlmann In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function Am J Kidney Dis 26 1995 924 933
22. A Jörres GM Gahl N Topley A Neubauer K Ludat C Müller J Passlick-Deetjen In vitro biocompatibility of alternative CAPD fluids: Comparison of bicarbonate buffered and glucose polymer-based solutions Nephrol Dial Transplant 9 1994 785 790
23. SR Kristensen FB Pedersen Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts Nephrol Dial Transplant 8 1993 163 167
24. L Gotloib V Wajsbrot A Shostak R Kushnier Population analysis of mesothelium in situ and in vivo exposed to bicarbonate-buffered peritoneal dialysis fluid Nephron 73 1996 219 227
25. H Yatzidis Enhanced ultrafiltration in rabbits with bicarbonate glycylglycine peritoneal dialysis solution Perit Dial Int 13 1993 302 306
26. M Feriani D Dissegna G La Greca J Passlick-Deetjen Short-term clinical study with bicarbonate-containing peritoneal dialysis solution Perit Dial Int 13 1993 296 301
27. M Feriani C Carobi G La Greca U Buoncristiani J Passlick-Deetjen Clinical experience with a 39 mmol/l bicarbonate-buffered peritoneal dialysis solution Perit Dial Int 17 1997 17 21
28. GA Coles R Gokal C Ogg F Jani D O'Donoghue GC Cancarini R Maiorca A Tranaeus D Faict C de Vos A randomised controlled trial of a bicarbonate- and bicarbonate/lactate-containing dialysis solution in CAPD Perit Dial Int 17 1997 48 51
29. M Feriani J Kirchgessner G La Greca J Passlick-Deetjen Bicarbonate CAPD Study Group Randomized long-term evaluation of bicarbonate-buffered CAPD solution Kidney Int 54 1998 1731 1738
30. CWH de Fijter LP Oe ECJM Heezius AJM Donker HA Verbrugh Low-calcium peritoneal dialysis fluid should not impact peritonitis rates in continuous ambulatory peritoneal dialysis Am J Kidney Dis 27 1996 409 415
31. CWH de Fijter HA Verbrugh LP Oe EDJ Peters J Van der Meulen AJM Donker J Verhoef Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis Kidney Int 42 1992 947 950
32. CWH de Fijter HA Verbrugh LP Oe E Heezius AJM Donker J Verhoef R Gokal Biocompatibility of a glucose polymer-containing peritoneal dialysis fluid Am J Kidney Dis 4 1993 411 418
33. RK Mackenzie CJ Holmes A Moseley JP Jenkins JD Williams GA Coles D Faict N Topley Bicarbonate/lactate and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage (PMØ) TNFα secretion J Am Soc Nephrol 9 1998 1499 1506
34. RK Mackenzie GA Coles JD Williams The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialysis-related peritonitis J Infect Dis 163 1991 837 842
35. RK Mackenzie GA Coles JD Williams Eicosanoid synthesis in human peritoneal macrophages stimulated with S epidermidis Kidney Int 37 1990 1316 1324
36. T Liberek N Topley A Jörres MM Petersen GA Coles GM Gahl JD Williams Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH Nephron 65 1993 260 265
37. N Topley In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions Perit Dial Int 17 1997 42 47
38. D Zemel ALT Imholz DR de Wart C Dinkla DG Struijk RT Krediet The appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent during stable and infectious CAPD Kidney Int 46 1994 1422 1430
39. N Topley Biocompatibility of peritoneal dialysis solutions and host defense Adv Ren Replace Ther 3 1996 309 311
40. B Rippe O Simonsen A Wieslander C Landgren Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis Perit Dial Int 17 1997 27 34
41. N Topley S Jones CJ Holmes R Mackenzie GA Coles D Faict JD Williams In vivo exposure to bicarbonate/lactate (TBL) peritoneal dialysis fluid (PDF) decreases pro-collagen I and TGF-β1 levels in dialysis effluent J Am Soc Nephrol 9 1998 290A (abstr)
42. SM McGregor N Topley A Jörres A Speekenbrink A Gordon GM Gahl BJR Junor JD Briggs JH Brock Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: Maturity, cytokine synthesis and arachidonic acid metabolism Kidney Int 49 1996 525 533
43. JW Dobbie Ultrastructure and pathology of the peritoneum in peritoneal dialysis R Gokal KD Nolph Ultrastructure and Pathology of the Peritoneum in Peritoneal Dialysis 1994 Kluwer Academic Berlin, Germany 17 44
44. A Fujimori H Naito T Miyazaki M Azuma S Hashimoto S Horikawa Y Tokukoda Elevation of interleukin-6 in the dialysate reflects peritoneal stimuli and deterioration of peritoneal function Nephron 74 1996 471 472
45. L Gotloib V Waisbrut A Shostak R Kushnier Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions Nephron 70 1995 466 477
46. L Gotloib V Waisbrut A Shostak R Kushnier Biocompatibility of dialysis solutions evaluated by histochemical techniques applied to mesothelial cell imprints Perit Dial Int 13 1993 201 207